Financial Services -
Banks - Regional - NASDAQ - US
$ 18.97
-0.528 %
$ 193 M
Market Cap
10.83
P/E
1. INTRINSIC VALUE
Balance Sheet
ESSA Bancorp, Inc.
| Current Assets | 255 M |
| Cash & Short-Term Investments | 255 M |
| Receivables | 0 |
| Other Current Assets | 0 |
| Non-Current Assets | 2.14 B |
| Long-Term Investments | -179 M |
| PP&E | 11.3 M |
| Other Non-Current Assets | 2.3 B |
| Current Liabilities | 280 M |
| Accounts Payable | 0 |
| Short-Term Debt | 280 M |
| Other Current Liabilities | 0 |
| Non-Current Liabilities | 1.68 B |
| Long-Term Debt | 10 M |
| Other Non-Current Liabilities | 1.67 B |
EFFICIENCY
Earnings Waterfall
ESSA Bancorp, Inc.
| Revenue | 66.5 M |
| Cost Of Revenue | 0 |
| Gross Profit | 66.5 M |
| Operating Expenses | 42.1 M |
| Operating Income | 21 M |
| Other Expenses | 3.97 M |
| Net Income | 17 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ESSA Bancorp, Inc.
| Net Income | 17 M |
| Depreciation & Amortization | -1.11 M |
| Capital Expenditures | -221 K |
| Stock-Based Compensation | 1.36 M |
| Change in Working Capital | 0 |
| Others | -6.97 M |
| Free Cash Flow | 13.2 M |
Wall Street Analysts Price Targets
ESSA Bancorp, Inc.
ESSA has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
0.80%
DIVIDEND YIELD
0.15 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
ESSA Bancorp, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
30.1 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
K12 Tutoring Earns ESSA Level II Validation, Confirming Impact on Student Achievement
An independently validated study highlighted K12 Tutoring's success in personalized, academic support An independently validated study highlighted K12 Tutoring's success in personalized, academic support
globenewswire.com
- 2 weeks ago
ESSA Bancorp, Inc. Announces Fiscal Second Quarter and Fiscal First Half 2025 Financial Results
STROUDSBURG, PA / ACCESS Newswire / April 23, 2025 / ESSA Bancorp, Inc. (the "Company") (NASDAQ:ESSA), the holding company for ESSA Bank & Trust (the "Bank"), a $2.2 billion asset financial institution providing full service commercial and retail banking, asset management and trust, and investment services in eastern Pennsylvania, today announced financial results for the fiscal second quarter and fiscal first half periods ended March 31, 2025. Net income was $2.7 million, or $0.29 per diluted share, for the three months ended March 31, 2025, compared with $4.6 million, or $0.48 per diluted share, for the three months ended March 31, 2024.
accessnewswire.com
- 3 weeks ago
CNB Financial Corporation Announces that ISS Recommends Shareholders Support the Proposal to Issue Common Stock in connection with the Merger with ESSA Bancorp, Inc., the Proposal to Approve the 2025 Omnibus Incentive Plan and the Say-on-Pay Proposal
CLEARFIELD, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB”) (NASDAQ: CCNE) is pleased to announce that leading independent proxy advisory firm Institutional Shareholder Services Inc (“ISS”) is recommending that CNB shareholders vote “FOR” each of (1) the proposal to issue shares of CNB common stock in connection with the merger of ESSA Bancorp, Inc. (“ESSA”) with and into CNB; (2) the proposal to approve the CNB Financial Corporation 2025 Omnibus Incentive Plan; and (3) the non-binding advisory resolution to approve the compensation of CNB's named executive officers in advance of the upcoming CNB Annual Meeting of Shareholders (the “Annual Meeting”).
globenewswire.com
- 1 month ago
Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=138642&wire=1 or contact Joseph E. Levi, Esq.
accessnewswire.com
- 1 month ago
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
NEW YORK , March 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ESSA Pharma Inc. ("ESSA Pharma Inc." or the "Company") (NASDAQ: EPIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ESSA Pharma Inc. investors who were adversely affected by alleged securities fraud between December 12, 2023 and October 31, 2024.
prnewswire.com
- 1 month ago
ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=138572&wire=1 or contact Joseph E. Levi, Esq.
accessnewswire.com
- 1 month ago
ESSA Pharma Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EPIX
NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=138426&wire=1 or contact Joseph E. Levi, Esq.
accessnewswire.com
- 1 month ago
ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2025 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses
globenewswire.com
- 1 month ago
Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX
NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=138345&wire=1 or contact Joseph E. Levi, Esq.
accessnewswire.com
- 1 month ago
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
NEW YORK , March 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ESSA Pharma Inc. (NASDAQ: EPIX). Shareholders who purchased shares of EPIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
prnewswire.com
- 1 month ago
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights – EPIX
NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ESSA Pharma Inc. ("ESSA Pharma Inc." or the "Company") (NASDAQ: EPIX) of a class action securities lawsuit.
globenewswire.com
- 1 month ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX
NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=138123&wire=1 or contact Joseph E. Levi, Esq.
accessnewswire.com
- 1 month ago
8. Profile
Summary
ESSA Bancorp, Inc. ESSA
COUNTRY
US
INDUSTRY
Banks - Regional
MARKET CAP
$ 193 M
Dividend Yield
0.80%
Description
ESSA Bancorp, Inc. operates as a bank holding company for ESSA Bank & Trust that provides a range of financial services to individuals, families, and businesses in Pennsylvania. The company accepts savings accounts, interest bearing demand accounts, checking accounts, money market accounts, club accounts, certificates of deposit and IRAs, and other qualified plan accounts, as well as commercial checking accounts. Its loan portfolio includes first mortgage loans for the purchase, construction, or refinancing of one- to four-family residential real estate property; commercial real estate loans; home equity loans and lines of credit; and commercial and other consumer loans, as well as loans secured by deposits and personal unsecured loans. In addition, the company offers insurance benefits consulting services, such as health insurance, life insurance, short term and long term disability, dental, vision, 401(K) retirement planning, and individual health products, as well as asset management and trust, and investment services. As of September 30, 2021, it operated 21 community offices, including seven offices in Monroe County, three offices in Lehigh County, five offices in Northampton County, one office in Lackawanna County, one office in Luzerne County, one office in Chester County, two offices in Delaware County, and one office in Montgomery County, Pennsylvania. The company was founded in 1916 and is headquartered in Stroudsburg, Pennsylvania.
Contact
200 Palmer Street, Stroudsburg, PA, 18360
https://ir.essabank.com
IPO
Date
April 4, 2007
Employees
236
Officers
Mr. Richard J. Howells
Director of Compliance
Mr. Joseph E. Bonsick
Chief Banking Officer
Mr. Thomas J. Grayuski
Chief Human Resource Officer & Senior Vice President
Mr. Robert L. Selitto
Senior Vice President & Controller
Mr. Allan A. Muto
Executive Vice President & Chief Financial Officer
Mr. James V. Fareri Esq.
General Counsel
Ms. Stephanie Lefferson
Corporate Secretary & Investor and Community Relations
Mr. Gary S. Olson
President, Chief Executive Officer & Director
Mr. Peter A. Gray
Senior EVice President & Chief Operating Officer
Mr. Charles D. Hangen
Executive Vice President & Chief Risk Officer